Gary Ingenito Catalyst Pharmaceuticals, Inc. (CPRX) insider trading activity

CPRX Quotes by TradingView

Gary Ingenito is Chief Med. & Reg. Officer of CATALYST PHARMACEUTICALS, INC.. Currently has a direct ownership of 68,873 shares of CPRX, which is worth approximately $1.7 Million. The most recent transaction as insider was on Feb 15, 2023, when has been sold 10,000 shares (Common Stock, par value $0.001 per share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 68.9K
12.34% 3M change
34.02% 12M change
Total Value Held $1.7 Million

GARY INGENITO Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 15 2023
BUY
Exercise of conversion of derivative security
-
10,000 Added 19.68%
40,802 Common Stock, par valu...
Dec 06 2022
SELL
Open market or private sale
$99,718 $16.85 p/Share
5,918 Reduced 16.12%
30,802 Common Stock, par valu...
Dec 06 2022
BUY
Exercise of conversion of derivative security
-
14,667 Added 28.54%
36,720 Common Stock, par valu...
Sep 14 2022
SELL
Open market or private sale
$2,240,810 $15.67 p/Share
143,000 Reduced 86.64%
22,053 Common Stock, par valu...
Sep 14 2022
BUY
Exercise of conversion of derivative security
$619,190 $4.33 p/Share
143,000 Added 56.51%
110,053 Common Stock, par valu...
Jun 22 2022
SELL
Open market or private sale
$40,665 $6.61 p/Share
6,152 Reduced 21.81%
22,053 Common Stock, par valu...
Jun 22 2022
BUY
Exercise of conversion of derivative security
$25,408 $4.13 p/Share
6,152 Added 17.91%
28,205 Common Stock, par valu...
Jun 21 2022
SELL
Open market or private sale
$947,958 $6.59 p/Share
143,848 Reduced 86.71%
22,053 Common Stock, par valu...
Jun 21 2022
BUY
Exercise of conversion of derivative security
$594,092 $4.13 p/Share
143,848 Added 46.44%
165,901 Common Stock, par valu...
Dec 07 2021
SELL
Open market or private sale
$25,248 $6.99 p/Share
3,612 Reduced 14.07%
22,053 Common Stock, par valu...
Dec 07 2021
BUY
Exercise of conversion of derivative security
-
14,667 Added 36.37%
25,665 Common Stock, par valu...
Dec 22 2020
SELL
Open market or private sale
$12,655 $3.45 p/Share
3,668 Reduced 25.01%
10,998 Common Stock, par valu...
Dec 22 2020
BUY
Exercise of conversion of derivative security
-
14,666 Added 50.0%
14,666 Common Stock, par valu...
GI

Gary Ingenito

Chief Med. & Reg. Officer
Coral Gables, FL

Track Institutional and Insider Activities on CPRX

Follow CATALYST PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CPRX shares.

Notify only if

Insider Trading

Get notified when an Catalyst Pharmaceuticals, Inc. insider buys or sells CPRX shares.

Notify only if

News

Receive news related to CATALYST PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CPRX